Fernandes Henrique Veiga
Oprichter bij LiMM Therapeutics SA
Profiel
Fernandes Henrique Veiga is the founder of LiMM Therapeutics SA. He is currently working as the Chief Scientific Officer at StemCell2MAX.
Actieve functies van Fernandes Henrique Veiga
| Bedrijven | Functie | Begin |
|---|---|---|
LiMM Therapeutics SA
 LiMM Therapeutics SA Financial ConglomeratesFinance LiMM Therapeutics SA operates as a biopharmaceutical corporation, that specializes in molecular cross-talk between neuronal and innate lymphoid cells within peripheral tissues. The firm develops medicines against inflammatory, infectious, and metabolic diseases. The company was founded by David Braga Malta and Henrique Veiga Fernandes and is headquartered in Paris, France. | Oprichter | - |
StemCell2MAX
 StemCell2MAX Miscellaneous Commercial ServicesCommercial Services StemCell2MAX engages in the provision of proprietary set of expansion solutions for hematopoietic stem cells (HSCs). The company was founded by Maria Brandão de Vasconcelos, Filipa Matos Baptista, Henrique Veiga-Fernandes, Diogo Fonseca-Pereira, and Sílvia Arroz-Madeira in 2015 and is headquartered in Cantanhede, Portugal. | Hoofd Techniek/Wetenschap/O&O | 01-01-2015 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
LiMM Therapeutics SA
LiMM Therapeutics SA Financial ConglomeratesFinance LiMM Therapeutics SA operates as a biopharmaceutical corporation, that specializes in molecular cross-talk between neuronal and innate lymphoid cells within peripheral tissues. The firm develops medicines against inflammatory, infectious, and metabolic diseases. The company was founded by David Braga Malta and Henrique Veiga Fernandes and is headquartered in Paris, France. | Finance |
StemCell2MAX
StemCell2MAX Miscellaneous Commercial ServicesCommercial Services StemCell2MAX engages in the provision of proprietary set of expansion solutions for hematopoietic stem cells (HSCs). The company was founded by Maria Brandão de Vasconcelos, Filipa Matos Baptista, Henrique Veiga-Fernandes, Diogo Fonseca-Pereira, and Sílvia Arroz-Madeira in 2015 and is headquartered in Cantanhede, Portugal. | Commercial Services |
